Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Cannabis Investors Are Watching Herbal Dispatch (CSE:HERB) (click to learn more) AI Wellness Stock Targeting Massive Growth (CSE: ALEN.U) (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Avadel Pharmaceuticals PLC AVDL

Healthcare Drug Manufacturers - Specialty & Generic
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is the LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its... see more

Current News (NDAQ:AVDL)

Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market

Business Wire 6 days ago

Avadel Pharmaceuticals Announces Outcome of the Court Sanction Hearing

GlobeNewswire 8 days ago

Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes

GlobeNewswire January 12, 2026

Avadel Pharmaceuticals Announces Completion of Enrollment in Phase 3 REVITALYZ(TM) Trial in Idiopathic Hypersomnia

GlobeNewswire December 18, 2025

Halper Sadeh LLC Encourages AVDL, CMA, KVUE Shareholders to Contact the Firm to Discuss Their Rights

GlobeNewswire December 14, 2025

Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plc - AVDL

PR Newswire December 12, 2025

Announcement relating to despatch of Rule 15 proposal

GlobeNewswire December 5, 2025

Halper Sadeh LLC Encourages GIFI, AVDL, JAMF, CDE Shareholders to Contact the Firm to Discuss Their Rights

GlobeNewswire December 4, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-GIFI, AVDL, SMLR, and CDE

GlobeNewswire December 4, 2025
View More News ››

Opinion & Analysis (NDAQ:AVDL)

Avadel Shares Rise and Shine on Positive Phase 3 Narcolepsy Study Findings

Streetwise Reports April 28, 2020

Avadel Pharma Shares Up 30% Upon Acceleration of Phase 3 REST-ON Study

Streetwise Reports September 24, 2019
View More Opinion ››

Bullboard Posts (NDAQ:AVDL)

Be the first to post on this bullboard.

Eshbal Functional Food Inc

Eshbal Functional Food Inc

Eshbal Functional Food Inc. researches, develops, and manufactures food products and dietary supplements Israel, North ...
View More »

Podcasts